Humana Inc.
Description
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
About
CEO
Mr. James A. Rechtin M.B.A.
Employees
67,600
Instrument type
Common Stock
Sector
Healthcare
Industry
Healthcare Plans
MIC code
XNYS
Address
Humana Building, Louisville, KY 40202, United States
×
![Enlarged Chart]()
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Oct 28, 2025 | — | — | — | — |
| Jul 29, 2025 | — | — | — | — |
| Apr 22, 2025 | — | — | — | — |
| Feb 11, 2025 | -2.20 | — | — | — |
| Oct 30, 2024 | 3.40 | 4.16 | 0.76 | 22.35% |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 19 | — | 25 |
| Average estimate | — | 6.86 | — | 16.91 |
| Low estimate | — | 5.12 | — | 16.05 |
| High estimate | — | 7.87 | — | 19.35 |
| Last year EPS | — | 7.23 | — | 16.15 |
[stock_revenue_estimate]
Growth estimates
Current qtr
-1,826.400%
Next qtr. (Mar 2025)
-5.160%
Current year
-38.080%
Next year (Dec 2025)
4.650%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total reported revenue | 106.37B | 92.87B | 83.06B | 77.16B | 64.89B |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating expense | |||||
| Research & development | — | — | — | — | — |
| Selling general and admin | — | — | — | 10.05B | 7.38B |
| Other operating expenses | 13.33B | 12.74B | 9.59B | 10.16B | 6.88B |
| Operating income | — | — | — | — | — |
| Non operating interest income | |||||
| Income | — | — | — | — | — |
| Expense | 493.00M | 401.00M | 326.00M | 283.00M | 242.00M |
| Other income expense | — | — | — | — | — |
| Pretax income | 3.38B | 3.57B | 3.35B | 4.60B | 3.46B |
| Tax provision | 836.00M | 762.00M | 485.00M | 1.31B | 763.00M |
| Net income | 2.48B | 2.80B | 2.93B | 3.37B | 2.71B |
| Basic EPS | 20.09 | 22.20 | 22.79 | 25.47 | 20.20 |
| Diluted EPS | 20.00 | 22.08 | 22.67 | 25.31 | 20.10 |
| Basic average shares | 123.87M | 126.42M | 128.69M | 132.20M | 134.05M |
| Diluted average shares | 123.87M | 126.42M | 128.69M | 132.20M | 134.05M |
| EBITDA | — | — | — | — | — |
| Net income from continuing op. | 2.48B | 2.80B | 2.93B | 3.37B | 2.71B |
| Minority interests | 5.00M | 4.00M | -1.00M | — | — |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | — | — | — | — | — |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 4.69B | 5.06B | 3.39B | 4.67B | 4.05B |
| Other short term investments | 16.63B | 13.88B | 13.19B | 12.55B | 10.97B |
| Accounts receivable | 2.04B | 1.67B | 1.81B | 1.14B | 1.06B |
| Other receivables | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Prepaid assets | — | — | — | — | — |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | — | — | — | — | — |
| Other current assets | — | — | — | — | — |
| Non current assets | |||||
| Properties | — | — | — | — | — |
| Land and improvements | — | — | — | — | — |
| Machinery furniture equipment | — | — | — | — | — |
| Construction in progress | — | — | — | — | — |
| Leases | — | — | — | — | — |
| Accumulated depreciation | — | — | — | — | — |
| Goodwill | 20.79B | 20.05B | 24.82B | 9.22B | 8.03B |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | 1.69B | 1.77B | 2.64B | 329.00M | 177.00M |
| Investments and advances | 17.75B | 15.01B | 14.11B | 14.94B | 12.44B |
| Other non current assets | — | — | — | — | — |
| Total liabilities | — | — | — | — | — |
| Current liabilities | |||||
| Accounts payable | 16.81B | 14.50B | 12.80B | 12.16B | 9.76B |
| Accrued expenses | — | — | — | — | — |
| Short term debt | 1.44B | 3.19B | 1.95B | 600.00M | 699.00M |
| Deferred revenue | — | — | — | — | — |
| Tax payable | — | — | — | — | — |
| Pensions | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — |
| Non current liabilities | |||||
| Long term debt | 10.21B | 7.94B | 10.54B | 6.06B | 4.97B |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | — | — | — | — | — |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | — | — | — | — | — |
| Shareholders equity | |||||
| Common stock | 33.00M | 33.00M | 33.00M | 33.00M | 33.00M |
| Retained earnings | 27.54B | 25.49B | 23.09B | 20.52B | 17.48B |
| Other shareholders equity | -999.00M | -1.30B | 42.00M | 391.00M | 156.00M |
| Total shareholders equity | 16.32B | 15.37B | 16.10B | 13.73B | 12.04B |
| Additional paid in capital | 3.35B | 3.25B | 3.08B | 2.71B | 2.82B |
| Treasury stock | 13.66B | 12.16B | 10.16B | 9.92B | 8.46B |
| Minority interest | 56.00M | 59.00M | 23.00M | — | — |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||
| Net Income | 2.48B | 2.80B | 2.93B | 3.37B | 2.71B | 1.68B | 2.45B | 614.00M | 1.28B | 1.15B | 1.23B | 1.22B | 1.42B | 1.10B | 1.04B | 647.15M | 833.68M | 487.42M | 308.48M | 280.01M | 228.93M | 142.76M | 117.17M | 90.05M | -382.42M | 129.00M | 173.00M | 12.00M | 190.00M | 176.00M | 89.00M | 71.70M | 355.00M | 318.20M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred Taxes | -167.00M | -100.00M | 15.00M | 195.00M | 162.00M | 194.00M | 132.00M | -71.00M | -2.00M | -64.00M | 42.00M | -80.00M | 22.00M | -199.00M | -26.79M | -22.01M | -32.74M | 70.06M | -38.36M | 53.61M | 32.25M | 49.56M | 56.10M | 19.29M | 4.97M | 26.00M | 40.00M | -25.00M | 13.00M | 58.00M | -13.00M | -52.00M | 21.00M | 200,000 |
| Stock-Based Compensation | 175.00M | 216.00M | 180.00M | 181.00M | 163.00M | 137.00M | 157.00M | 115.00M | 109.00M | 98.00M | 92.00M | 82.00M | 67.00M | 63.00M | 65.87M | 55.37M | 42.13M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Cash Items | 113.00M | 70.00M | 40.00M | 49.00M | 90.00M | 107.00M | 155.00M | 201.00M | 131.00M | 74.00M | 130.00M | 105.00M | 92.00M | 58.00M | 18.42M | 102.92M | 63.18M | -13.54M | -370.36M | 60.15M | -5.57M | -298.41M | 146.45M | 206.50M | 481.14M | 297.00M | -160.00M | -274.00M | 69.00M | 21.00M | — | 315.30M | -12.00M | -22.10M |
| Accounts Receivable | -337.00M | -54.00M | -280.00M | -85.00M | -32.00M | -164.00M | 426.00M | -158.00M | -180.00M | -264.00M | -251.00M | 326.00M | -106.00M | -46.00M | -59.97M | -152.89M | 60.75M | 37.65M | -225.28M | -47.07M | 2.47M | -2.46M | -14.65M | -8.23M | 92.53M | 66.00M | -47.00M | -31.00M | -4.00M | — | 16.00M | 146.00M | -71.00M | -59.50M |
| Accounts Payable | 915.00M | 975.00M | 104.00M | 2.14B | 1.14B | 252.00M | 105.00M | -413.00M | 501.00M | 582.00M | 109.00M | -41.00M | 256.00M | — | — | — | -7.98M | 1.32B | 452.29M | -46.24M | 19.91M | 150.81M | -165.48M | -202.99M | -74.38M | -301.00M | 111.00M | 296.00M | -92.00M | -7.00M | -27.00M | — | -6.00M | — |
| Other Assets & Liabilities | -497.00M | -387.00M | -380.00M | 89.00M | 553.00M | -1.26B | 157.00M | 1.28B | -998.00M | -384.00M | -41.00M | 4.00M | 37.00M | 757.00M | 116.87M | -281.31M | -453.83M | 1.37B | 388.32M | -42.25M | 45.02M | 148.35M | -157.30M | -219,000 | 12.57M | -13.00M | — | 81.00M | -83.00M | -43.00M | 73.00M | -45.00M | 61.00M | 290.60M |
| Operating Cash Flow | 2.69B | 3.52B | 2.61B | 5.94B | 4.79B | 954.00M | 3.58B | 1.57B | 837.00M | 1.19B | 1.31B | 1.62B | 1.79B | 1.73B | 1.15B | 349.24M | 505.20M | 3.28B | 515.09M | 258.22M | 323.01M | 190.60M | -17.70M | 104.40M | 134.41M | 204.00M | 117.00M | 59.00M | 93.00M | 205.00M | 138.00M | 436.00M | 348.00M | 527.40M |
| Investing Activities | ||||||||||||||||||||||||||||||||||
| Capital Expenditures | -794.00M | -1.12B | -1.32B | -964.00M | -736.00M | -612.00M | -524.00M | -527.00M | -522.00M | -528.00M | -437.00M | -410.00M | -336.00M | -222.00M | -183.94M | -261.57M | -212.73M | -183.53M | -161.35M | -83.61M | -90.09M | -112.14M | -114.97M | -135.07M | -88.93M | -104.00M | -73.00M | -72.00M | -54.00M | -26.00M | -20.00M | -236.00M | -398.00M | -308.00M |
| Net Intangibles | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Acquisitions | -233.00M | 2.36B | -4.19B | -709.00M | — | -2.25B | -31.00M | -7.00M | 1.02B | 54.00M | -153.00M | -1.24B | -226.00M | -833.00M | -12.44M | -422.92M | -493.49M | -28.06M | -402.84M | -141.81M | — | — | -27.89M | -12.91M | -14.81M | — | -669.00M | -6.00M | -697.00M | -162.00M | — | — | — | — |
| Purchase of Investments | -7.55B | -6.05B | -7.20B | -9.13B | -6.36B | -4.69B | -6.27B | -6.57B | -6.74B | -2.88B | -3.26B | -3.22B | -3.68B | -4.59B | -7.20B | -5.68B | -4.20B | -4.27B | -3.72B | -4.11B | -4.57B | -2.57B | -1.87B | -1.21B | -796.03M | -1.04B | -608.00M | -440.00M | -402.00M | -523.00M | — | — | — | — |
| Sale of Investments | 5.09B | 3.80B | 6.14B | 7.73B | 5.82B | 4.47B | 3.88B | 5.74B | 6.56B | 3.29B | 2.67B | 2.90B | 2.88B | 3.83B | 5.53B | 5.87B | 3.06B | 3.41B | 3.48B | 3.70B | 4.29B | 2.55B | 1.90B | 1.13B | 863.71M | 1.20B | 658.00M | 356.00M | 731.00M | 337.00M | — | — | — | — |
| Investing Cash Flow | -3.49B | -1.01B | -6.56B | -3.07B | -1.28B | -3.09B | -2.94B | -1.36B | 320.00M | -63.00M | -1.18B | -1.97B | -1.36B | -1.81B | -1.86B | -498.32M | -2.55B | -1.65B | -767.28M | -624.08M | -373.16M | -128.16M | -118.81M | -178.03M | 17.78M | 28.00M | -654.00M | -174.00M | -450.00M | -402.00M | -416.00M | -331.00M | -608.00M | -404.60M |
| Financing Activities | ||||||||||||||||||||||||||||||||||
| Long-Term Debt Issuance | 2.54B | 1.98B | 5.48B | 2.09B | 987.00M | 1.00B | 1.78B | — | — | 1.73B | — | 990.00M | — | — | — | 749.25M | — | 880.38M | — | — | 299.14M | — | 824.98M | 520.00M | — | 123.00M | 300.00M | 222.00M | 250.00M | — | 383.00M | 30.00M | 275.00M | — |
| Long-Term Debt Payments | -2.43B | -3.38B | -2.08B | -1.40B | -1.05B | -350.00M | -800.00M | — | -33.00M | -500.00M | — | -36.00M | — | -71.00M | -100.08M | -1.73B | -1.36B | -600.00M | -324.23M | — | -265.00M | -55.88M | -856.95M | — | -93.00M | -330.00M | — | -250.00M | -51.00M | — | — | -231.00M | -183.00M | -253.30M |
| Other Financing Charges | 725.00M | 1.97B | -310.00M | -890.00M | -569.00M | -640.00M | 1.82B | 1.09B | -281.00M | -907.00M | -142.00M | -375.00M | -363.00M | -235.00M | 186.56M | -613.47M | -147.63M | 109.14M | — | 18.97M | 28.23M | 6.60M | -6.65M | -3.79M | -13.80M | 35.00M | 13.00M | 1.00M | 11.00M | — | -13.00M | -5.00M | -2.00M | 500,000 |
| Financing Cash Flow | -956.00M | -2.29B | 3.02B | -1.96B | -2.35B | -830.00M | -1.01B | 721.00M | -606.00M | -787.00M | -762.00M | -86.00M | -1.09B | -485.00M | -36.44M | -2.25B | -413.72M | 675.64M | -414,000 | -75.05M | -94.93M | -179.19M | -373.25M | -183.10M | -169.81M | 51.00M | 679.00M | 195.00M | 210.00M | — | 370.00M | -343.00M | -22.00M | -359.50M |
| Other Cash Details | ||||||||||||||||||||||||||||||||||
| End Cash Position | 4.69B | 5.06B | 3.39B | 4.67B | 4.05B | 2.34B | 4.04B | 3.88B | 2.57B | 1.94B | 1.14B | 1.31B | 1.38B | 1.67B | 1.61B | 1.97B | 2.04B | 1.74B | 732.02M | 580.08M | 931.40M | 721.36M | 651.42M | 657.56M | 978.29M | 913.00M | 627.00M | 322.00M | 182.00M | 272.00M | — | — | — | — |
| Income Tax Paid | 997.00M | 758.00M | 227.00M | 1.13B | 518.00M | 631.00M | 1.50B | 916.00M | 1.18B | 1.03B | 734.00M | 745.00M | 874.00M | 785.00M | 627.23M | 347.35M | 443.90M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest Paid | 394.00M | 354.00M | 285.00M | 258.00M | 212.00M | 195.00M | 216.00M | 185.00M | 187.00M | 143.00M | 146.00M | 110.00M | 114.00M | 112.00M | 112.53M | 73.81M | 67.95M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 2.98B | 3.45B | 920.00M | 4.68B | 4.55B | 1.56B | 3.53B | 1.41B | 345.00M | 1.09B | 1.28B | 1.51B | 1.73B | 2.02B | 1.24B | 720.74M | 985.02M | 1.49B | 459.78M | 233.71M | 311.87M | 209.27M | 33.99M | -94.66M | 128.81M | -49.00M | 206.00M | 269.00M | 96.00M | 259.00M | 157.00M | 370.00M | 107.00M | 414.10M |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | Sep 30, 2024 | 3,818,200 | 1.13B | 3.17% |
| Dodge & Cox Stock Fund | Sep 30, 2024 | 3,306,800 | 977.26M | 2.75% |
| Vanguard 500 Index Fund | Sep 30, 2024 | 3,153,307 | 931.90M | 2.62% |
| Vanguard Specialized-Health Care Fund | Oct 31, 2024 | 1,594,883 | 471.34M | 1.32% |
| Fidelity 500 Index Fund | Nov 30, 2024 | 1,487,791 | 439.69M | 1.24% |
| SPDR S&P 500 ETF Trust | Nov 30, 2024 | 1,488,518 | 439.90M | 1.24% |
| iShares Core S&P 500 ETF | Nov 30, 2024 | 1,360,716 | 402.13M | 1.13% |
| Washington Mutual Investors Fund | Dec 31, 2024 | 1,310,778 | 387.37M | 1.09% |
| Vanguard/Windsor Fund Inc. | Oct 31, 2024 | 1,047,859 | 309.67M | 0.87% |
| Vanguard Index-Value Index Fund | Sep 30, 2024 | 1,017,522 | 300.71M | 0.85% |
Article
Will Lower Commercial Premiums Hurt Humana's Q4 Earnings?
HUM's Q4 results are likely to suffer a blow due to escalating operating costs, partly offset by membership growth in the Individual and Group Medicare Advantage business lines.
Feb 7, 2025
Article
Countdown to Humana (HUM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top -and-bottom-line estimates for Humana (HUM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
Feb 6, 2025
Article
Sword Health Appoints Bruce Broussard, Former CEO of Humana, as Board Advisor
With its groundbreaking AI Care platform fueling rapid growth, Sword is transforming healthcare through AI. The addition of Bruce Broussard as Board Advisor will be instrumental in enhancing industry expertise and shaping the company's future. With its groundbreaking AI Care platform fueling rapid growth, Sword is transforming healthcare through AI. The addition of Bruce Broussard as Board Advisor will be instrumental in enhancing industry expertise and shaping the company's future.
Feb 6, 2025
